Explore PMOS Research
Search 20,749 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active — and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies2,661–2,680 of 20,710
All studies
Network Pharmacology Integrated Molecular Docking Analysis Identifies Potential Phytochemicals in Stachys lavandulifolia against Polycystic Ovary Syndrome
Evaluation of Luteinizing Hormone, Follicle Stimulating Hormone and LH/FSH Ratio in Polycystic Ovary Syndrome of Reproductive Women
Modeling adipose tissue dysfunction in polycystic ovary syndrome in vitro using 2D and 3D cell culture systems
PRESSING CANCEL: INFLUENCE OF STIMULATION PROTOCOL ON CYCLE CANCELLATION (CC) AND OUTCOMES IN POLYCYSTIC OVARY SYNDROME (PCOS) PATIENTS UNDERGOING FRESH IN VITRO FERTILIZATION (IVF) CYCLES
Prediction of Transabdominal Ultrasound for Detection of Polycystic Ovary Using Hormonal Profile as Gold Standard.
Differences in Prevalence of Polycystic Ovary Syndrome Diagnosis Across Sexual Orientation in a Longitudinal Cohort of U.S. Adults
"COMPARATIVE EVALUATION OF ABRUS PRECATORIUS (GUNJA) IN THE MANAGEMENT OF OBESITY-RELATED POLYCYSTIC OVARY SYNDROME(PCOS)"
Table 1_Adverse pregnancy and perinatal outcomes in women with polycystic ovary syndrome undergoing assisted reproductive technology: a systematic review and meta-analysis.docx
What are the potential benefits and harms of using metformin in women with polycystic ovary syndrome according to Cochrane reviews?
Surya Namaskar as a Gender-sensitive Intervention: Addressing Social Physique Anxiety (SPA) Issues in Women with PCOS.
Pathophysiology, diagnostics and promising therapies of polycystic ovary syndrome: A systematic review of scientific literature
Data Sheet 1_Method of invigorating spleen and replenishing kidney and resolving phlegm for obesity-type polycystic ovary syndrome: a network meta-analysis and summary of herbal prescription regularity.docx
Natural History of Cardiovascular Disease in Young Women: Cardiometabolic Risk, Atherosclerotic Cardiovascular Disease and Cardiac Function Is Exacerbated in Those With Polycystic Ovary Syndrome
ASSOCIATION BETWEEN DIETARY PROTEIN-TO-CARBOHYDRATE RATIO AND SYMPTOMS PROFILE OF POLYCYSTIC OVARY SYNDROME IN OBESE FEMALES AGED 15–30 YEARS: A CROSS-SECTIONAL STUDY
Unlocking artemisinin's potential in polycystic ovary syndrome treatment: A call for controlled human trials
MiR-126-3p Inhibits the Apoptosis of Ovarian Granulosa Cells in Polycystic Ovary Syndrome by Targeting SLC7A5
Exploring the Role of Abnormal Qi Movement in Polycystic Ovary Syndrome Based on the Gut-Brain Axis
The role of macrophages in polycystic ovary syndrome: A review
Image 1_Exploration of the molecular mechanism of melatonin against polycystic ovary syndrome based on a network pharmacology approach and experimental validation.tiff